Malin D H, Lake J R, Shenoi M, Upchurch T P, Johnson S C, Schweinle W E, Cadle C D
University of Houston-Clear Lake, TX 77058, USA.
Psychopharmacology (Berl). 1998 Dec;140(3):371-7. doi: 10.1007/s002130050778.
Nitric oxide synthesis contributes to opiate tolerance and dependence. Nicotine dependence and abstinence syndrome in the rat appear to involve opiate mechanisms. Therefore, it was postulated that nitric oxide synthase (NOS) activity might be essential for the expression of nicotine abstinence syndrome. Twenty-one rats were rendered dependent by SC infusion of 9 mg/kg per day nicotine tartrate via Alzet osmotic minipump. Rats were pretreated SC with vehicle alone, or with 18 or 30 mg/kg of the NOS inhibitor L-NNA (nitro-L-arginine). Thirty minutes later, rats were challenged by 1 mg/kg of the nicotinic antagonist mecamylamine SC and observed for 30 additional minutes. Rats pretreated with vehicle displayed a total of 68.7+/-8.0 mecamylamine-precipitated abstinence signs (mean+/-SEM), while those receiving 18 or 30 mg/kg L-NNA had 12.7+/-2.0 and 5.1+/-1.7 signs, respectively. All three groups differed significantly from one another according to Dunn's post-hoc procedure. Rats pretreated with L-NNA combined with an excess of the NOS substrate L-arginine had significantly more mecamylamine-precipitated abstinence signs than rats receiving L-NNA combined with D-arginine. Also, D-NNA, which does not selectively bind to NOS, was significantly less effective than L-NNA in preventing mecamylamine-precipitated abstinence syndrome. Additional studies determined the effect of L-NNA on spontaneous nicotine abstinence syndrome. Rats were assessed for abstinence signs at 17 and 20 h after termination of nicotine infusion. They received injections of 9, 18, or 30 mg/kg L-NNA SC or vehicle alone immediately before the 20-h observation; all rats were observed for 30 min. Signs at 20 h (post-injection) as a percentage of signs at 17 h (pre-injection) declined significantly as a function of L-NNA dose. Once again, this effect was attenuated significantly more by co-administration of L-arginine than by D-arginine. The overall pattern of results suggests that nitric oxide synthesis is critical to the expression of nicotine abstinence syndrome.
一氧化氮的合成与阿片类药物耐受性和依赖性有关。大鼠的尼古丁依赖性和戒断综合征似乎涉及阿片类机制。因此,有人推测一氧化氮合酶(NOS)活性可能对尼古丁戒断综合征的表现至关重要。通过Alzet渗透微型泵每天皮下注射9mg/kg酒石酸尼古丁使21只大鼠产生依赖性。大鼠皮下预处理单独使用赋形剂,或使用18或30mg/kg的NOS抑制剂L-NNA(硝基-L-精氨酸)。30分钟后,大鼠皮下注射1mg/kg烟碱拮抗剂美加明进行激发,并再观察30分钟。用赋形剂预处理的大鼠共出现68.7±8.0个美加明诱发的戒断症状(平均值±标准误),而接受18或30mg/kg L-NNA的大鼠分别有12.7±2.0和5.1±1.7个症状。根据邓恩事后检验程序,所有三组之间差异显著。用L-NNA联合过量的NOS底物L-精氨酸预处理的大鼠比接受L-NNA联合D-精氨酸的大鼠有明显更多的美加明诱发的戒断症状。此外,不选择性结合NOS的D-NNA在预防美加明诱发的戒断综合征方面明显不如L-NNA有效。进一步的研究确定了L-NNA对自发性尼古丁戒断综合征的影响。在尼古丁输注终止后17和20小时评估大鼠的戒断症状。在20小时观察前,它们立即皮下注射9、18或30mg/kg L-NNA或单独使用赋形剂;所有大鼠观察30分钟。20小时(注射后)的症状作为17小时(注射前)症状的百分比,随着L-NNA剂量的增加而显著下降。同样,与D-精氨酸共同给药相比,L-精氨酸共同给药对这种效应的减弱更为显著。结果的总体模式表明一氧化氮的合成对尼古丁戒断综合征的表现至关重要。